4.7 Review

Innate immunity and chronic immune activation in HCV/HIV-1 co-infection

Journal

CLINICAL IMMUNOLOGY
Volume 135, Issue 1, Pages 12-25

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2009.12.005

Keywords

HCV; HIV-1; Innate immunity; IFN alpha; Chronic immune activation

Categories

Funding

  1. Swedish Research Council
  2. Swedish International Development Agency
  3. Swedish Foundation for Strategic Research
  4. Swedish Cancer Foundation
  5. Karolinska Institutet
  6. Karolinska University Hospital

Ask authors/readers for more resources

Innate immune responses are critical in the defense against viral infections. NK cells, myeloid and plasmacytoid dendritic cells, and invariant CD1d-restricted NKT cells mediate both effector and regulatory functions in this early immune response. In chronic uncontrolled viral infections such as HCV and HIV-1, these essential immune functions are compromised and can become a double edged sword contributing to the immunopathogenesis of viral disease. In particular, recent findings indicate that innate immune responses play a central role in the chronic immune activation which is a primary driver of HIV-1 disease progression. HCV/HIV-1 co-infection is affecting millions of people and is associated with faster viral disease progression. Here, we review the role of innate immunity and chronic immune activation in HCV and HIV-1 infection, and discuss how mechanisms of innate immunity may influence protection as well as immunopathogenesis in the HCV/HIV-1 co-infected human host. (C) 2009 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available